Financials
- Market Capitalization 804.88 M
- Employee 489
- Founded 2007
- CEO Mike Raab
- Website www.ardelyx.com
- Headquarter Delaware, United States
- FIGI BBG001WH4DQ3
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-22.42
Fiyat/satışlar oranı
3.45
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 2514 | ABUS Arbutus Biopharma Corporation - Common Stock | 4.15 USD | -1.66% | -11.13% | -18.95% | -2.35% | 821.07 M USD | ||
| 2526 | AVBP ArriVent BioPharma, Inc. - Common Stock | 16.46 USD | -1.61% | +37.97% | -43.44% | -20.41% | 811.61 M USD | ||
| 2550 | SANA Sana Biotechnology, Inc. - Common Stock | 2.62 USD | -6.09% | -10.88% | -16.29% | -38.50% | 784.32 M USD | ||
| 2551 | GERN Geron Corporation - Common Stock | 1.22 USD | -0.81% | +1.67% | -10.29% | -3.94% | 783.82 M USD |